EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps

Prem Prakash iD, Berwin Singh Swami Vetha, Rajasree Chakraborty iD, Tara-Yesomi Wenegieme iD, Sepiso K Masenga iD, Gladson Muthian, Muthukumar Balasubramaniam, Celestine N Wanjalla iD, Antentor O Hinton iD, Annet Kirabo iD, Clintoria R Williams iD, Azeez Aileru iD und 1 weitere

Circulation Research · 24.05.2024 · 134 (11)

DOI: 10.1161/circresaha.124.323979 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 24.05.2024. Verfasst von Prem Prakash und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Center for AIDS Health Disparities Research (P.P., R.C., G.M., M.B., C.D.), Meharry Medical College, Nashville, TN. Hauptthemen laut MEDLINE: HIV Infections, Hypertension. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 328 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDA NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV type 1 (HIV-1) is the causative agent of AIDS. Since the start of the epidemic, HIV/AIDS has been responsible for ≈40 million deaths. Additionally, an estimated 39 million people are currently infected with the virus. HIV-1 primarily infects immune cells, such as CD 4+ (cluster of differentiation 4 + ) T lymphocytes (T cells), and as a consequence, the number of CD 4+ T cells progressively declines in people living with HIV. Within a span of ≈10 years, HIV-1 infection leads to the systemic failure of the immune system and progression to AIDS. Fortunately, potent antiviral therapy effectively controls HIV-1 infection and prevents AIDS-related deaths. The efficacy of the current antiviral therapy regimens has transformed the outcome of HIV/AIDS from a death sentence to a chronic disease with a prolonged lifespan of people living with HIV. However, antiviral therapy is not curative, is challenged by virus resistance, can be toxic, and, most importantly, requires lifelong adherence. Furthermore, the improved lifespan has resulted in an increased incidence of non-AIDS–related morbidities in people living with HIV including cardiovascular diseases, renal disease, liver disease, bone disease, cancer, and neurological conditions. In this review, we summarize the current state of knowledge of the cardiovascular comorbidities associated with HIV-1 infection, with a particular focus on hypertension. We also discuss the potential mechanisms known to drive HIV-1–associated hypertension and the knowledge gaps in our understanding of this comorbid condition. Finally, we suggest several directions of future research to better understand the factors, pathways, and mechanisms underlying HIV-1–associated hypertension in the post-antiviral therapy era.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHypertensionHumansRisk FactorsHIV-1Animals

Stichwörter der Autor:innen

cardiovascular diseasescytopathogenic effect, viralnoncommunicable diseasesquality of lifesodium chloride, dietary

Autor:innen und Institutionen

  • The Center for AIDS Health Disparities Research (P.P., R.C., G.M., M.B., C.D.), Meharry Medical College, Nashville, TN.
  • Department of Microbiology, Immunology, and Physiology (P.P., R.C., G.M., M.B., C.D.), Meharry Medical College, Nashville, TN.
  • Department of Biochemistry, Cancer Biology, Pharmacology and Neuroscience (P.P., R.C., G.M., M.B., C.D.), Meharry Medical College, Nashville, TN.
  • Department of Foundational Sciences and Research, School of Dental Medicine, East Carolina University, Greenville, NC (B.S.S.V., A.A.).
  • Department of Neuroscience, Cell Biology and Physiology, Boonshoft School of Medicine, College of Science and Mathematics, Wright State University, Dayton, OH (T.-Y.W., C.R.W.).
  • HAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Kabwe, Zambia (S.K.M.).

ORCID-Profile: Prem Prakash, Rajasree Chakraborty, Tara-Yesomi Wenegieme, Sepiso K Masenga, Celestine N Wanjalla, Antentor O Hinton, Annet Kirabo, Clintoria R Williams, Azeez Aileru, Chandravanu Dash

Förderung

  • NIAID NIH HHS
  • NIDA NIH HHS
  • NIMHD NIH HHS

Zitieren

APA

Prakash, P., Swami Vetha, B. S., Chakraborty, R., Wenegieme, T. Y., Masenga, S. K., Muthian, G., Balasubramaniam, M., Wanjalla, C. N., Hinton, A. O., Kirabo, A., Williams, C. R., Aileru, A., & Dash, C. (2024). HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps. Circulation Research, 134(11). https://doi.org/10.1161/circresaha.124.323979

Vancouver

Prakash P, Swami Vetha BS, Chakraborty R, Wenegieme TY, Masenga SK, Muthian G, et al. HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps. Circulation Research. 2024;134(11). doi:10.1161/circresaha.124.323979

BibTeX
@article{Prakash2024,
  author = {Prakash, Prem and Swami Vetha, Berwin Singh and Chakraborty, Rajasree and Wenegieme, Tara-Yesomi and Masenga, Sepiso K and Muthian, Gladson and Balasubramaniam, Muthukumar and Wanjalla, Celestine N and Hinton, Antentor O and Kirabo, Annet and Williams, Clintoria R and Aileru, Azeez and Dash, Chandravanu},
  title = {HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps},
  journal = {Circulation Research},
  year = {2024},
  volume = {134},
  number = {11},
  doi = {10.1161/circresaha.124.323979}
}
Kostenlos starten →